| ORIGINAL ARTICLE |
|
| Year : 2018 | Volume
: 3
| Issue : 1 | Page : 28-32 |
|
|
Quality assessment of the Saudi initiative for asthma guideline
Fahad Alfhaid1, Mohammed Aljulifi1, Tahir Ansari2, Abdullah Al-Olayan3, Mohammed Almansour1, Talal Shakhs Alghamdi1
1 Department of Clinical Sciences-Family Medicine, College of Medicine, Majmaah University, Al Majma'ah, Kingdom of Saudi Arabia
2 Department of Clinical Sciences-Medicine, College of Medicine, Majmaah University, Al Majma'ah, Kingdom of Saudi Arabia
3 Department of Clinical Sciences-Paediatric Pulmonology, College of Medicine, Majmaah University, Al Majma'ah, Kingdom of Saudi Arabia
Correspondence Address:
Dr. Abdullah Al-Olayan
Department of Clinical Sciences-Paediatric Pulmonology, College of Medicine, Majmaah University, Al Majma'ah 11952
Kingdom of Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijas.ijas_10_18
|
|
|
Objective: The objective of this study is to assess the quality of Saudi initiative for asthma (SINA) guideline using appraisal of guidelines for research and evaluation (AGREE II) tool.
Design: This study design was methodological evaluation of SINA Guidelines using the AGREE II instrument.
Place and Duration of Study: This study was conducted from September to December 2017 in the college of medicine, Majmaah University, Saudi Arabia.
Methods: The appraisers assessed the quality of SINA guideline. A descriptive statistical analysis through the calculation of the total, standardized-score value by each reviewer, and the value per domain were performed. Six reviewers evaluated the guideline independently; four of them were family physicians, one was Internist, and the other was pediatric pulmonologist.
Results: We found that clarity of presentation for SINA scored the best (64%). The guideline scored average on the domain related to “scope and purpose” and “stakeholder involvement.” The lowest score was in “applicability” and “editorial independence” domain (25%), respectively. However, the overall quality of the SINA guideline was low, and the reviewer suggested the use of the current guideline after modification.
Conclusion: The results of our studies emphasize the need for addressing the domains with low scores including rigor of development, applicability, and editorial independence. However, the reviewers recommend using SINA guideline for asthma management with taking into consideration the modifications that were noted during the appraisal. We also recommend using AGREE II tool to develop and improve the next version of SINA guideline.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
